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Abstract 
Purpose: To isolate high purity pectolinarigenin from Cirsium japonicum and evaluates its anti-
proliferative potential and induction of apoptosis activity in MCF-7 breast cancer cell.  
Methods: Pectolinarigenin was purified by the combination of silica gel and Sephadex LH-20 column 
chromatography. The structure was identified by 1H-nuclear magnetic resonance (NMR), 13C-NMR and 
electrospray ionization tandem mass spectrometry (ESI-MS) analyses. The anti-proliferation activity of 
pectolinarigenin was also evaluated by methylthiazolyldiphenyl-tetrazolium bromide (MTT) and colony 
formation assays in MCF-7 breast cancer cell.  
Results: Pectolinarigenin showed potent anti-proliferation activity by inducing apoptosis and 
downregulation of Bcl2 expression in MCF-7 breast cancer cell. Protein expression of Bcl2 was almost 
completely inhibited upon the treatment with 25 µM pectolinarigenin.  
Conclusion: A rapid method to isolate high purity pectolinarigenin from C. japonicum and as well as 
evaluate its anti-proliferative potential and induction of apoptosis in MCF-7 breast cancer cells is 
presented for the first time. Induction of apoptosis of MCF-7 is via downregulation of Bcl2 expression. 
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Cirsium japonicum belongs to the family of 
Compositae and is widely used in traditional 
Chinese medicine (TCM) for the treatment of 
haemorrhage, hepatitis, hypertension and blood 
circulation [1]. Pharmacological studies show that 
the extract of C. japonicum and its major 
constituents possess anti-tumor [1, 2], anti-
diabetic [3], antioxidant [4], anti-inflammatory [4], 
and antifungal [5]. C. japonicum contains 
significant amounts of flavonoid compounds, the 
principal characteristic of the flavonoid 
compounds are pectolinarin and pectolinarigenin 
(Figure 1), which exhibited powerful anti-diabetic, 









Figure 1: Chemical structure of pectolinarigenin (1) 
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A previous study has shown that the methanol 
extract of C. japonicum inhibits MCF-7 cell 
growth at both proliferation and apoptosis levels 
[8]. However, the active components have not 
been isolated and identified. Bcl2 gene is an 
important regulator of apoptosis, which is an 
over-expression in many solid organ tumours 
including breast cancer [9]. Increasing evidence 
supports their modulated expression in breast 
cancer cells and in many cases, their relation to 
chemotherapy response, outcome, and overall 
prognosis, as well as their value are important 
potent therapeutic targets [10].  
The aim of this study was to determine a quick 
method to isolate high purity pectolinarigenin 
from C. japonicum and assess the biological 




Plant material and equipment 
 
The aerial parts of C. japonicum were purchased 
from the Chinese herbal medicine market in 
Zhang Shu (Jiang Xi, China) in July 2010 and 
authenticated by Qingzhi Kong of Hubei 
University of Chinese Medicine. A voucher 
specimen (2010-07) has been deposited in the 
Hubei University of Chinese Medicine. The 1H-
and 13C-NMR spectra were recorded on a Bruker 
Avance-400 FT-NMR spectrometer, with TMS 
internal standard. ESI-MS were recorded on 
3200 Q-trap ESI-MS spectrometer (ABI, 
American). Column chromatography was carried 
with silica gel (200-300 mesh) and Sephadex LH-
20 (Pharmacia Co.). All the organic solvents 
used were of analytical grade and purchased 
from Sinopharm Chemical Reagent Co., LtdS 
(Shanghai, China). Bcl2 and Bax were 
purchased from Santa Cruz Biotechnology, Inc. 
Caspase 3 was obtained from Cell Signaling 
Technology. β-actin and Anti-poly (ADP-ribose) 
polymerase (PARP) were obtained from Sigma 
Chemical Company (Sigma-Aldrich). The cell 
culture medium Dulbecco’s Modified Eagle 
Medium (DMEM); high glucose, without sodium 
pyruvate) and fetal bovine serum (FBS) were 
purchased from Hyclone Company (Logan, UT, 
USA). Acrylamide-bis solution (30 %; 29:1) was 
bought from Bio-Radlaboratories (Hercules, CA , 
USA), Inc. Protein content was tested using a 
BCA kit (Thermo Scientific).  
 
Cell line and culture  
 
The human breast cancer cells line, MCF-7, was 
purchased from American Type Culture 
Collection. MCF-7 Cells were cultured in DMEM 
medium supplemented with 10% heat inactivated 
fetal bovine serum (FBS), 100 units/ml penicillin 
and 100 µg/ml streptomycin at 37 ˚C in a 
humidified incubator with 5% CO2 (all reagents 
from Invitrogen, Carlsbad, CA). The cells were 
maintained in log phase by seeding twice a week 
at a density of 1 × 105/ml, and the experiments 
were performed 1 day after trypsinization. 
 
Extraction and isolation of pectolinarigenin 
 
The powdered air-dried aerial parts of C. 
japonicum (1 kg) were extracted three times with 
6 L 80 % ethanol/10 % HCl (4:1, v/v) in a conical 
flask and refluxed at 80 °C for 2 h. The solvent 
was evaporated in vacuum and then the 
concentrated extract was partitioned with 
chloroform. The chloroform fraction was 
successively purified on silica gel (200-300 
mesh) with CHCl3-MeOH gradient and on 
Sephadex LH-20 with CHCl3-MeOH (1:1) to yield 
compound 1 (61 mg). 
 
Cell growth determination by MTT assay 
 
MTT assay measures the ability of viable cells to 
reduce yellow 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide to purple formazan 
by mitochondrial succinate dehydrogenase 
(SDH). Cells (1×103) were seeded onto a 96-well 
plate in triplicate with 1, 5, 10, 25 and 50 µM 
pectolinarigenin for 24 h, and then the cells were 
washed three times with fresh medium and 
cultured for an additional 7 days. The medium 
was removed, and the MCF-7 cells were then 
incubated in DMEM medium containing 0.5 
mg/ml MTT for an additional 3 h. The medium 
was removed, and dimethyl sulfoxide (DMSO) 
was added to dissolve the formazan. Absorbance 
was read at 490 nm in an ELISA reader (Bio-Rad 
iMARKTM Mcroplate Reader). The absorbance of 
cultures treated with 0.1 % DMSO was regarded 
as 100% cell viability. 
 
Colony forming assay 
 
For colony expansion assay, MCF-7 cells were 
plated in 6-well plates at a density of 1000 
cells/well and allowed to adhere overnight. The 
culture medium was replaced with media 
containing indicated concentrations of 
pectolinarigenin. After exposure for 24 h, the 
cells were washed twice with phosphate buffered 
saline (PBS). Fresh medium was then added, 
and the cells cultured at 37 °C in humidified 5 % 
CO2 atmosphere for 8 - 10 days. The cells were 
viewed regularly under the microscope for colony 
formation. At termination, the culture medium 
was decanted, the cells rinsed with PBS and 
stained with crystal violet (0.5 % in 95 % ethanol) 
for 5 min after fixation with 10 % formaldehyde 
for 5 min.  
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Western blotting assay 
 
The cells were washed twice with cold PBS and 
harvested in 150 µl of Lysis Buffer RIPA (150 
mM NaCl; 50 mM Tris pH 8; 0.1 % SDS; 0.5 % 
sodium deoxicolate; 1 % Nonidet P40; 5 mM 
EDTA, 1 mM PMSF, 1 µg/ml leupeptin, 1 µg/ml 
aprotinin and 2 mM DTT). The cell homogenates 
were centrifuged at 10,000 g for 20 min at 4 °C. 
The resulting supernatant was used as a cellular 
protein for Western blotting analysis. The protein 
content in the lysates was measured by BCA 
protein assay. Equal amounts of proteins were 
electrophoresed in SDS-PAGE and the proteins 
transferred to polyvinylidene difluoride (PVD) 
membranes. The detection was achieved using 
the immobilon western chemiluminescent HRP 
Substrate kit (Millipore). The primary antibodies 
used are: PARP (Santa Cruz Biotechnology, 
Inc.), Caspase 3 (Cell Signaling Technology), 
Bcl2 (Santa Cruz Biotechnology, Inc.), Bax 





Statistical analyses were performed with 
GraphPad Prism software. Values are expressed 
as mean ± SEM. Pair-wise comparisons were 
performed using Student’s t test (two-tailed). P < 




NMR and ESI-MS spectral data 
 
Pectolinarigenin (1): yellow crystal (methanol), 
C17H14O6, UV (MeOH) λmax: 336, 273 nm, ESI-
MS m/z: 313.1[M-H]-. 1H-NMR (400 MHz, DMSO-
d6, δ, ppm, J/Hz): 6.86 (1H, s, H-3), 6.61 (1H, s, 
H-8), 8.02 (2H, d, J=8.8, H-2', 6'), 7.10 (2H, d, 
J=8.8, H-3', 5'), 12.97 (1H, s, OH-5), 10.78 (1H, 
s, OH-7), 3.94 (3H, s, 6-OCH3), 3.86(3H, s, 4'-
OCH3).
 13C-NMR (100 MHz, DMSO-d6): 163.8 
(C-2), 103.5 (C-3), 182.6 (C-4), 153.2 (C-5), 
131.8 (C-6), 157.8 (C-7), 94.7 (C-8), 152.9 (C-9), 
104.6(C-10), 123.3 (C-1'), 128.7 (C-2', 6'), 114.9 
(C-3', 5'), 162.7 (C-4'), 60.4 (6-OCH3), 55.9 (4'-
OCH3). The NMR data were consistent with the 
literature [11]. 
 
Effect of pectolinarigenin on MCF-7 cell 
growth 
 
Treatment with pectolinarigenin inhibited cell 
proliferation in MCF-7 (Figure 2). The inhibitory 
effect on MCF-7 treated with 1, 5, 10, 25 and 50 
µM pectolinarigenin were 16, 31, 61, 82, and 89, 
respectively, compared with controls. This result 
suggested that pectolinarigenin caused a 





































Figure 2: Inhibition of proliferation MCF-7 cells. MCF-
7 cells were exposed to different concentrations of 
pectolinarigenin. Data represent mean normalized 
optical densities ± SEM (n = 3); *p <0 .05, ***p < 0.001 
compared control  
 
Colony formation  
 
To further investigate the inhibitory effect of 
pectolinarigenin on MCF-7 growth, colony 
formation assay was carried out. The results also 
revealed that pectolinarigenin elicited anti-
proliferation activity in MCF-7 in a dose-
dependent manner (Figure 3).  
 
 
Figure 3: Inhibition of colony formation in MCF-7 
breast cancer cells by pectolinarigenin  
 
Pectolinarigenin modulates apoptosis-related 
protein expression 
 
The results show that 5 and 25 µM 
pectolinarigenin efficiently induced the cleavage 
of PARP and Caspapse 3 in MCF-7 cells after 
24-h treatment (Figure 4). At the same time, a 
significant difference was found in the expression 
of Bcl2 and Bax. MCF-7 treated with 5 and 25 
µM pectolinarigenin as it resulted in the 
downregulation of anti-apoptotic protein Bcl2 
expression. However MCF-7 treated with 5 µM 
pectolinarigenin, even upto 25 µM 
pectolinarigenin there was no change (p > 0.05) 





Pectolinarigenin has been reported as an anti-
tumor agent in mice with S180 and H22 tumor 
cells [1] and many other cancer cell lines, 
including lung cancer, colon cancer and renal 
cancer cells [2,7]. In the present study, we found 
that 5, 10, 25 and 50 µM pectolinarigenin 
significantly inhibit MCF-7 breast cancer cell 
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proliferation. Pectolinarigenin, at a concentration 
of 50 µM, almost completely inhibited MCF-7 
colony formation.  
 
 
Figure 4: Modulation of apoptosis related protein 
expression in MCF-7 cells by pectolinarigenin. 
 
Induction of apoptosis by pectolinarigenin is an 
important way to inhibit cancer cell growth. 
Caspase 3 is a member of the cysteine-aspartic 
acid protease family and a critical executioner of 
apoptosis [12]. PARP is a DNA repair enzyme, 
and cleavage of PARP facilitates cellular 
disassembly. Cleavage of Caspase 3 and PARP 
serves as markers of cell undergoing apoptosis 
[13]. Our findings indicate that 5 and 25 µM 
pectolinarigenin induced cleavage of Caspase 3 
and PARP and that pectolinarigenin inhibits 
MCF-7 cell proliferation via induction of MCF-7 
apoptosis. The apoptosis-preventing effect of 
Bcl2 is counteracted by the pro-apoptotic protein, 
Bax; furthermore, the ratio of Bax/Bcl-2 mixture 
determines sensitivity to different apoptotic 
stimuli. While 5 and 25 µM pectolinarigenin 
resulted in downregulation of Bcl2 protein 
expression, the isolate had no effect on Bax 
protein expression. Thus, downregulation of Bcl2 
protein expression is the probable mechanism of 




Induction of apoptosis of MCF-7 via 
downregulation of Bcl2 expression is the proable 
mechanism of action of pectolinarigen. 
Pectolinarigen inhibition of breast cancer cell 
MCF-7 proliferation not only an addition to the 
current knowledge of the compound’s properties 
but also presents a novel potential therapeutic 
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